Morgan Stanley raised the firm’s price target on Viavi (VIAV) to $9.30 from $8.60 and keeps an Underweight rating on the shares following the fiscal Q4 report. The firm says the company’s weaker service provider demand was offset by data center upside. It still sees limited earnings power for Viavi.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIAV:
- Viavi Solutions: Strong Financial Performance and Strategic Positioning Justify Buy Rating
- Viavi price target raised to $12 from $11 at B. Riley
- Susquehanna upgrades Viavi to Positive on bottoming of earnings
- Viavi price target raised to $12 from $11 at UBS
- Viavi upgraded to Positive from Neutral at Susquehanna